WRITE
FOR US

About

Hi, I’m Jarret Morrow, M.D., and I write here at Supplement Updates (jarretmorrow.com) to provide consumers with an objective, unbiased, and informed perspective about dietary supplements, vitamins, and nutraceutical products along with other general health and fitness tips.

I started Supplement Updates in 2007 to help consumers cut through the overwhelming amount of inaccurate information  in this industry.  If you’re focused on health and fitness, subscribe to my blog [FREE] to stay up-to-date on the latest scientific information provided by a former industry insider.  To contact me, locate the contact form by clicking on the link at the top of this blog.

A Little Bit About Me…

I grew up in Canada with a diverse background and interest in sports.  Like many Canadians who played hockey growing up, I thought that I would play in the NHL one day… Sadly, it wasn’t in the cards.

Following a bad ski accident involving a serious injury to my left knee, I had to give up playing hockey and moved on to other sports.  This included competing on the Alberta Provincial Cycling and the Alberta Provincial Biathlon (winter) Teams as well as my high school swim team.

In cycling, I previously won the Alberta Provincial Cycling Championships in numerous events (individual pursuit, road race, and time trial).  I also managed to place 3rd in the Canadian National Cycling Championships as well (road race).

While competing and training hard for bicycle racing, in particular, I developed a strong interest in health and nutrition which lead me to my first degree, a BSc in Specialization Pharmacology, and ultimately a Doctor of Medicine degree as well.

Though you’re now more likely to find me lifting weights in the gym, golfing, skiing (knee permitting), surfing (while on vacation), rollerbladding, or just at an Edmonton Oilers game than competing in any sports, I still maintain an interest and passion in sports nutrition.

More About – Jarret Morrow, M.D.

Dr. Morrow received his Doctor of Medicine from The University of Alberta in June 2001 and prior to that, received his Bachelor of Science with Specialization in Pharmacology with Distinction, also from The University of Alberta, in June 1997.

Dr. Morrow is the former President and Chief Science Officer of University Health Industries.  In that capacity, Dr. Morrow worked in formulating nutraceutical products which were marketed in National TV advertising campaigns in the United States. Dr. Morrow is a member of Mensa Canada.

Selected Publications:

  1. Jean-Michel Le Melledo, Jorge Perez-Parada, Jarret Morrow, Francois Bellavance, Nathalie Lara, Farideh Jahandar, Robert Granger, Glendon Tait, and Karen McManus.  Pentagastrin-induced hemoconcentration in healthy volunteers and patients with panic disorder: effect of pretreatment with ethinyl estradiol.  J Psychopharmacol. 2011 Jan;25(1):71-7
  2. Psychiatric Clinical Skills, Revised 1ST edition.  Jarret Morrow, Mark Katz, Gary Rodin.  Editor:  David S. Goldbloom.  Publisher:  Center for Addiction and Mental Health, Toronto.  2010.  Chapter 16 “Assessment of Medical/Surgical Patients.”
  3. Jean-Michel Le Melledo, Jorge Perez-Parada, Jarret Morrow, Francois Bellavance, Nathalie Lara, Farideh Jahandar, Robert Granger, Glendon Tait, and Karen McManus.  Pentagastrin-induced hemoconcentration in healthy volunteers and patients with panic disorder: effect of pretreatment with ethinyl estradiol.  Journal of Psychopharmacology;2009: October 13th.
  4. Jarret D. Morrow, Mark Katz, Gary Rodin.  Assessment of Medical/Surgical Patients.  Psychiatric Clinical Skills.  Editor:  David S. Goldbloom.  Publisher:  Elsevier.  Toronto, Ontario. 2006. 215-227.
  5. Morrow J, Castillo M, Gill L, Bradley J, Lara N, Chrapko W, Le Melledo J.  Antipanic Effects of Paroxetine on the Panic Response to Pentagastrin in Healthy Controls and Patients with Panic Disorder.  Psychosomatic Medicine 2004; 64 Abstract #1585.
  6. Morrow J, Tait G, McManus K, Bellavance F, Lara N, and Le Mellédo J. Pentagastrin-induced Release of Free Fatty Acids in Healthy Volunteers and Patients with Panic Disorder.  Effect of Pretreatment with Ethinyl Estradiol.  J Psychiatry Neurosci 2003;28(2):127-33.
  7. Morrow J, Tait G, McManus K, Bellavance F, Lara N, and Le Mellédo J. Pentagastrin-induced Hemoconcentration in Healthy Volunteers and Patients with Panic Disorder.  Effect of Pretreatment with Ethinyl Estradiol.  Psychosomatic Medicine 2002;64(1): 117 (Abstract).
  8. Le Melledo J-M, Lara N, Bailey D, Morrow J, Archer S, Juracz P, Radomski M, Chrapko W, Baker G, Bellavance F.  Anxiety Disorders and cerebro-cardiovascular risks.  ADAA Toronto, March 2003.7.
  9. Le Melledo J-M, McManus K, Tait G, Morrow J, Bellavance F. Investigation of the Cardiovascular Risks Associated with Panic Disorder.  Biological Psychiatry meeting, Washington 1999.
  10. Le Melledo J-M, McManus K, Tait G, Morrow J, Bellavance F. Investigation of the Cardiovascular Risks Associated with Panic Disorder.  CCNP meeting, Halifax, June 1999.

Presentations:

  1. Evidence-Based Medicine Approach to Nutraceutical Development.  Natural Product’s Association Conference.  Las Vegas, Nevada.  July 22nd, 2007.
  2. Jarret Morrow.  A Review of the Cerebro/Cardiovascular Risks Associated with Panic Disorder and the Treatment Implications Pertaining to SSRI’s.  CANMAT Mood and Anxiety Disorder Conference.  Calgary, Alberta.  November 2005.
  3. S-Adenosyl Methionine (SAMe) A Review of the Medical Literature Pertaining to its use in the Treatment of Depressive Disorders.  Grand Rounds, University of Alberta Hospital, Edmonton, June 2004.
  4. The Neurobiology of Panic Disorder:  New Evidence for the Interaction of Cholecystokinin and Serotonin Receptors in the Etiology and Treatment of Panic Disorder.  Alberta Psychiatric Association Meeting.  Banff.  March 2004.  (Lundbeck Award for best original research presentation by a resident.)
  5. Jarret Morrow.  The Effect of Pretreatment with Zoloft on Panic-Induced Hemoconcentration in Healthy Volunteers and Patients with Panic Disorder.  American Psychosomatic Society 61st  Annual Scientific Meeting, Orlando, Florida March 2004.
  6. Morrow J, Bedard A, Tannock R, Ickowicz A.  Comparing Behavioral Response to MPH in ADHD Inattentive and Combined Subtypes.  Presented at the Alberta Psychiatric Association Meeting, Banff. March 2003.
  7. Cerebrovascular Risk Associated with Panic Disorder due to Transient Cholesterol Elevations During Panic Attacks.  Presented at the American Psychosomatic Society 60th Annual Scientific Meeting, Barcelona, Spain.  March 2002.
  8. Cerebrovascular Risk Associated with Panic Disorder.  Presented at the Alberta Psychiatric Association Meeting, Banff. March 2002.
  9. Prinzmetal’s Variant Angina, a Case Report.  Presented at Cardiology Grand Rounds, Royal Alexandra Hospital, Edmonton. April 2002.
  10. The Mind/Body Interaction.  Can emotions/mood states have physiological consequences?  Grand Rounds, Grey Nuns Hospital, Edmonton, December 2001.
  11. Cardiovascular Risks Associated with Panic Disorder.  Presented at the 31st  Annual Medical Student’s Research Day.  Edmonton. September 1998.

Social Media

 

WRITE
FOR US
Back to Top
Copyright © 2012 Dietary Supplement Updates · Powered by the Genesis Theme Framework